1Xiao HB, Gibson DC. Natrual history of abnormal conduction and its relation to prognosis in patients with dilated cadiomyopathy[ J]. Int J Cardiol,1996 ;53( 1 ) :163-70.
2Shamim W, Francis DP, Yousufuddin M, et al. Intraventricular conduction delay: a prognostic marker in chronic heart failure[ J]. Int J Cardiol, 1999;70:171-8.
3Molhoek MD, Jeroen J, et al. Effectiveness of esynehronization therapy in patients with end-stage heart failure[ J ]. Am J Cardiol, 2002 ;90:379-83.
4Auricchio A, Stellbrink C, Sack S. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay[ J]. J Am Coll Am J Cardiol,2002 ;39:2026-33.
7Birnie DH, Tang AS. The problem of non-response to cardiac resynchronization therapy[ J]. Currop Cardiol, 2006 ;21 ( 1 ) :20.
8Yu CM, Fung WH, Zhang Q, et al. Understanding nonresponders of cardiac resynchronization therapy-current and future perspectives[ JJ. J Cardiovasc Electrophysiol,2005 ; 16(10) : 1117.
1Varrna C. Pace for heart failure[J]. Lancet, 2001,357: 1277-1283.
2St John,Sutton MG, Plappert T, et al. Multicenter Insync randomized Clinical Evaluation (MIRCLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure[J]. Circulation, 2003, 107:1985-1990.
7Delfaut P, Saksena S, Prakash A, et al. Long-term outcome in patients with drug-refractory atrial flutter and fibrillation after single-anddual-site right atrial pacing for arrhythmia prevention[J]. JACC, 1998,32:1900-1908.
8Linde C. Biventricular pacing in patients with severe heart failure: has the time come[J]? Heart, 2000,84: 123-124.
9Kay GN, Bourge RC. Biventricular pacing for congestive heart failure: questions of who, what, where, why, how, and how much[J]. Am Heart J,2000,140:821-823.
10Barold SS. Biventricular cardiac pacing: promising new therapy for congestive heart failure[J]. Chest, 2000,118 : 1819-1821.
4Claure-Del Granado R, Macedo E, Chertow GM, et aL Effluent volume in continuous renal replacement therapy overestimates the delivered dose of dialysis[J]. Clin J Am Soc Nephrol, 2011, 6(3) :467-475.
5Prowle JR, Schneider A, Bellomo R. Clinical review: optimal dose of continuous renal replacement therapy in acute kidney injury[J]. Crit Care, 2011,15 (2) : 207.
6Tabak'ian EA, Zaruba AIu, Rogoza AN, et al. Determination of brain natriuretic peptide levels and its N-terminal fragment for the evaluation of renal replacement therapies efficiency in patients with decompensated chronic heart failure [J]. Ter Arkh, 2010,82 (8) : 24-29.
7Granado RC;Macedo E;Chertow GM.Effluent volume in continuous renal replacement therapy overestimates the delivered dose of dialysis,2011(03).
8Prowle JR;Schneider A;Bellomo R.Clinical review:Optimal dose of continuous renal replacement therapy in acute kidney injury,2011(02).
9Cohen TJ, Klein J. Cardiac resynchronization therapy for treatment of chronic heart failure. J Invasive Cardiol, 2002,14( 1 ) :48-53.
10Garrigue S, Reuter S, Labeque JN, et al. Usefulness of biventricu- lar pacing in patients with congestive heart failure and right bundle branch block[ J]. Am J Cardiol, 2001,88 ( 12 ) : 1436-1441.
